about
Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosisSystematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancerSuccessful Treatment of Scrub Typhus-Associated Hemophagocytic Lymphohistiocytosis With Chloramphenicol: Report of 3 Pediatric Cases and Literature ReviewOptimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisSecondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysisRetrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007.Cerebral hemorrhage due to tuberculosis meningitis: a rare case report and literature review.Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease.Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitisInvasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China.Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients.Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.Effectiveness and tolerability of NSAIDs in the prophylaxis of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis.Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis.Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients.Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohortMethimazole-induced cholestatic hepatitis: two cases report and literature reviewStratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Parabolic relationship between sex-specific serum high sensitive C reactive protein and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injuryPreoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.Multifocal skeletal tuberculosis: experience in diagnosis and treatment.The quality of randomized controlled trials on DanShen in the treatment of ischemic vascular disease.Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.Platelet-to-Lymphocyte Ratio: A Novel Prognostic Factor for Prediction of 90-day Outcomes in Critically Ill Patients With Diabetic Ketoacidosis.Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.
P50
Q26824664-00E2361E-448D-45A0-A6D0-ADCD03336B4AQ26864932-1CF23226-6829-436A-A49A-ED2A963937DFQ27021015-8995DCBA-01A5-47ED-88EB-853B940B674EQ28087211-5573B47F-2F29-4379-AD34-7841ABC2A87AQ28291828-B80D327F-580B-480E-B319-89E400700A45Q30871022-9712FBB5-4F2F-4B89-A365-9B6D3B9F72C4Q31032483-25EBD9FB-A2F8-44EF-83EC-C4B58CA60407Q31090448-C27B3447-CFC1-430D-9260-9347EE52ECC6Q31137291-E72FFD77-4166-4EED-B7E1-56A7754FF669Q33319646-DB20952F-638A-48EA-B452-D66A118DB46EQ33402093-656C149F-75A4-40F9-AAAB-EB59F03AFBCBQ33596891-84BC6912-2DEF-4972-B7B8-2725998F9E48Q33734215-5447E678-B428-41A2-A4A3-354DCFED0E1EQ34409744-8BC272D7-F8F2-41C1-BB61-36C74A54C431Q35135319-C182D548-21F9-409F-B7E0-7D24DA8EC0FFQ35137859-6992895D-771E-4725-9AF4-97E1B793D243Q35561845-C0B86EB0-A91B-469F-AC0C-7250226C92CDQ35658230-1BB69737-E78E-40EC-B47B-B16D13FB2202Q35660038-3BECEABC-CF87-4C44-AC78-9F7B94E22BE2Q35778052-3EA5D402-0069-4CB9-B7F8-44A6888FD0C3Q35906051-469B68E2-42DC-4C17-9555-F8ACF60BD372Q36151646-2487F231-7E46-43D4-8170-37990D6997EFQ36152268-25F546DE-620C-4940-AE9D-3A9854BBB15CQ36185812-942D5E12-E8C6-4640-8998-5D78B714A0B9Q36260667-637A4395-9D7C-43E0-BF73-40EBF572DAD2Q36413124-4C5D66AC-56CC-4826-949B-02E20BE23D5CQ36414158-D89F365B-AD7D-4E48-814E-545261E9FC3EQ36782685-80B1BA25-C772-4E02-9AC0-7900A47C65B9Q36905681-9634384F-E8E8-435A-AB29-E3E276E52648Q36905761-A31E7D9D-3DF8-4028-BA68-8E638F30AC47Q37046588-285A5772-E8D9-4F42-83A3-0534FF77FA9BQ37082777-C0C6FB01-4542-43FF-8664-C8901D772EB2Q37157508-967B7C64-9B16-474D-8221-7081AD0D442DQ37295401-308DEAB7-007B-4FC8-9893-A940C929DE94Q37338881-AAA1564F-AA36-4154-8FA6-F14AD692FCFEQ37440115-8B8FBAF0-A6E9-4F41-8BFB-52FAFC8FB351Q37474738-4AE08EF4-DF98-4B1A-A739-888896156392Q37517243-A7D303FB-CDBB-4E82-A70D-1D503824D387Q37624105-5D4E6702-4F20-4328-B862-5F48D150AF7AQ37761660-2C3F30F1-B155-4BDB-AE5D-EB121CFF8974
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ming-Hua Zheng
@ast
Ming-Hua Zheng
@en
Ming-Hua Zheng
@es
Ming-Hua Zheng
@nl
Ming-Hua Zheng
@sl
type
label
Ming-Hua Zheng
@ast
Ming-Hua Zheng
@en
Ming-Hua Zheng
@es
Ming-Hua Zheng
@nl
Ming-Hua Zheng
@sl
altLabel
Associate Prof. Zheng
@en
Doctor Zheng
@en
prefLabel
Ming-Hua Zheng
@ast
Ming-Hua Zheng
@en
Ming-Hua Zheng
@es
Ming-Hua Zheng
@nl
Ming-Hua Zheng
@sl
P106
P31
P496
0000-0003-4984-2631